Deepar Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 2.25 M
- Revenue Growth 26.78%
- Profit Growth 1.68%
- Ebitda 1341.21%
- Net Worth 39.59%
- Total Assets 53.69%
About Deepar Pharmaceuticals
Deepar Pharmaceuticals Private Limited (DPPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 May 2016 (Eight years and nine months 22 days old ). Its registered office is in Jaipur, Rajasthan, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹2.25 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Sanjay Bansal, Shradha Arora, Nisha, and One other member serve as directors at the Company.
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24290RJ2016PTC054843
- Company No.
054843
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 May 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
What products or services does Deepar Pharmaceuticals Private Limited offer?
Deepar Pharmaceuticals Private Limited offers a wide range of products and services, including Cardiovascular Drugs & Medication, Kidney Drugs, Nutraceuticals & Dietary Supplements, Fitness Supplements, Sexual Wellness Products, Female Hygiene Products & Test Kits, Common Disease Medicines, Antihistamines, Ayurvedic,Herbal Products & Medicine, Ayurvedic Pain Relief Oil.
Who are the key members and board of directors at Deepar Pharmaceuticals?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Bansal  | Director | 05-May-2016 | Current |
| Shradha Arora | Director | 05-May-2016 | Current |
| Nisha | Director | 05-May-2016 | Current |
| Nishant Arora | Director | 05-May-2016 | Current |
Financial Performance of Deepar Pharmaceuticals.
Deepar Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 26.78% increase. The company also saw a slight improvement in profitability, with a 1.68% increase in profit. The company's net worth Soared by an impressive increase of 39.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Deepar Pharmaceuticals?
In 2019, Deepar Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹2.25 M
Charges Breakdown by Lending Institutions
- Others : 0.23 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Dec 2018 | Others | ₹2.25 M | Satisfied |
How Many Employees Work at Deepar Pharmaceuticals?
Unlock and access historical data on people associated with Deepar Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Deepar Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Deepar Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.